MABVAX THERAPEUTICS HOLDINGS, INC. Notes Payable
MABVAX THERAPEUTICS HOLDINGS, INC. had Notes Payable of $2.64 million as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable
us-gaap:NotesPayable · last filed 2018-11-13
- 2018-09-30: Notes Payable $2.64M.
- 2018-06-30: Notes Payable $2.54M.
- 2018-03-31: Notes Payable $2.95M.
- 2017-12-31: Notes Payable $3.30M.
| Period end | Notes Payable |
|---|---|
| 2018-09-30 | $2.64M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.54M 10-Q · filed 2018-10-15 |
| 2018-03-31 | $2.95M 10-Q · filed 2018-10-15 |
| 2017-12-31 | $3.30M 10-K/A · filed 2018-10-15 |
| 2017-09-30 | $3.65M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $3.95M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $4.27M 10-Q · filed 2017-05-22 |
| 2016-12-31 | $4.36M 10-K · filed 2017-03-01 |
| 2016-09-30 | $3.08M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $4.09M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $3.98M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-07 |